Replies to post #14943 on Coro Global Inc (CGLO)

[conix]

Interesting chart, cpner.

First, I am in both these stocks. More in one than the other based on my buying where I can trade for profits and not in a protracted downtrend.

But your last post. Note the one year chart below of the two stocks in question. The one you hate did a RS in August of 2010 and I was not even aware of them until December.

The chart shows that you can make money AFTER a RS. I was lucky that I was not even tempted to buy before their August RS. But I have traded and accumulated there since Dec. Simple question--despite the RS in one, which stock has done better in the past twelve months?
.


I also got into MDFI. Again, I trade. Did OK on some of these spikes. But I never keep all my shares when a stock runs. I always let some go. It keeps me in the game if I take profits. But I got concerned on the increase in the shares outstanding BECAUSE it looks like it is headed to a necessary RS and, based on what you apparently experienced in CTYX, that is painful.

Now, if you are correct and CTYX puts out 100 million more shares out, I would be concerned--but I was told when CTYX called me (BTW, I did not ask them how many shares they have sold--my bad) that they were raising just enough to pay for some outsourced projects.

In other words, we will see on Nov. 15 or sooner when the shares number comes out...they would have to have 156 million shares out (still much lower than here). But I would be surprised if it is over 100 million total. I could be wrong and I will certainly say so if I am. But at least I am not looking at the probability of it having more than 4.5 Billion shares out.

Getting back to MDFI-- the possibilities of a pop here is good IF MDFI does not have alot more shares out and they surprise on revenues. There are alot of people here, IMO, who would love to feel more confident in averaging down if they had more info. That buying alone would make MDFI spike higher.

Either way, personal medical records (PMR)are here to stay. It comes down to who executes and finds the creative path to profitability. Jury's out on both. I am in both.

GL